Drawing for DRUGX

USPTO serial 87232404

DRUGX

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
REEVES, APRIL ELIZABETH
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DRUGX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John C. Cain

JOHN C. CAIN FLECKMAN & MCGLYNN, PLLC8945 LONG POINT RD, SUITE 120HOUSTON, TX 77055UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Computer application software for mobil phones and hand-held computers, namely, software for identifying pharmaceuticals for use with specific diseases or patient applications; Computer software for predicting performance of chemical or pharmaceutical combinations in treating patients and instructional user guides sold as a unit; Computer software for identifying pharmaceuticals for use with specific diseases or patient applications; Database management software for predicting the effectiveness of medicines in treating patients; Downloadable databases in the field of medicineACTIVE—
042Software as a service (SAAS) services featuring software for predicting the effectiveness of medicines in treating patients; Software as a service (SAAS) services featuring software for predicting novel drug targets for various diseases and predicting known drug candidates for treating disease targetsACTIVE—
044Health care services, namely, providing a database in the field of disease treatment information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Providing information in the field of cancer prevention, screening, diagnosis and treatment; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Providing a website featuring information in the field of the diagnosis and treatment of cancer and various other diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 6, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 6, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 4, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 3, 2019EX5GSOU EXTENSION 5 GRANTED—
Dec 3, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 26, 2019EXT5SOU EXTENSION 5 FILED—
Nov 26, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 28, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 24, 2019EX4GSOU EXTENSION 4 GRANTED—
May 24, 2019EXT4SOU EXTENSION 4 FILED—
May 24, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 29, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 27, 2018EX3GSOU EXTENSION 3 GRANTED—
Nov 27, 2018EXT3SOU EXTENSION 3 FILED—
Nov 27, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 29, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 25, 2018EX2GSOU EXTENSION 2 GRANTED—
May 25, 2018EXT2SOU EXTENSION 2 FILED—
May 25, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 29, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 27, 2017EX1GSOU EXTENSION 1 GRANTED—
Nov 27, 2017EXT1SOU EXTENSION 1 FILED—
Nov 27, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 30, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 4, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 4, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 15, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 23, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 16, 2017DOCKASSIGNED TO EXAMINER—
Nov 17, 2016MPMKNOTICE OF PSEUDO MARK E-MAILED—
Nov 16, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 14, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance